Artificial Intelligence In Genomics Market Research Reports, 2022 to 2028 | MarketDigits

NEW YORK - Oct. 9, 2022 - PRLog -- According to a new market research report "Artificial Intelligence In Genomics Market by Offering (Software, Services), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), Technology (ML, Computer Vision) - Global Forecast to 2028" published by MarketDigits (www.marketdigits.com), the total market is expected to reach USD billion by 2028, at a CAGR of 53% during the forecast period from 2022 to 2028.

This report covers a sub-market in this field - the Artificial Intelligence In Genomics Market by offering type in detail, segmenting the market as Software, Services. The scope of the report covers technology segment which includes Machine Learning, Deep Learning, Supervised Learning, Reinforcement Learning, and Unsupervised Learning. The segment Functionality type segregated into Genome Sequencing Gene Editing Clinical Workflows Predictive Genetic Testing & Preventive Medicine. Moreover, it provides in-sights on Application that segregates into Diagnostics Drug Discovery & Development Precision Medicine Agriculture & animal Research Other Applications. Lastly, the Artificial Intelligence In Genomics Market is segmented by geography across North America, Europe, Asia-Pacific (APAC), ROW (Rest of the World) and regional market further sub-segmented by countries.

The report deals with all the driving factors, opportunities and challenges with respect to the global Artificial Intelligence In Genomics Market, which are helpful in identifying trends and key success factors for the industry. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long term landscapes.

Browse the full report at https://marketdigits.com/artificial-intelligence-in-genomics-market/

Major players in Artificial Intelligence In Genomics Market include IBM, Microsoft, NVIDIA Corporation, Deep Genomics, BenevolentAI, Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc., Cambridge Cancer Genomics, SOPHiA GENETICS, Data4Cure Inc., Precision Life Ltd , Genoox Ltd., Lifebit, Diploid, FDNA Inc., DNAnexus Inc., Empiric Logic, and Engine Biosciences Pte. Ltd. among others.

Major Classifications are as follows:

By Offering

• Software
• Services

By Technology

• Machine Learning
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technologies
• Other Technologies

By Functionality

• Genome Sequencing
• Gene Editing
• Clinical Workflows
• Predictive Genetic Testing & Preventive Medicine

By Application

• Diagnostics
• Drug Discovery & Development
• Precision Medicine
• Agriculture & animal Research
• Other Applications

By End user

• Pharmaceutical & Biotech Companies
• Healthcare Providers
• Research Centers, Academic Institutes, &
• Government Organizations
• Other End Users

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Rest of the World (RoW)